Abstract
Sinemet CR, a controlled release carbidopa/levodopa preparation, was compared to conventional carbidopa/levodopa in a double blind, placebo-controlled trial. Comparable clinical benefits and adverse effects were noted with the two medications. However significantly less frequent dosing was necessary with Sinemet CR.
Original language | English (US) |
---|---|
Pages (from-to) | 8-10 |
Number of pages | 3 |
Journal | The Nebraska medical journal |
Volume | 76 |
Issue number | 1 |
State | Published - Jan 1991 |
Externally published | Yes |
ASJC Scopus subject areas
- General Medicine